Clinical Trials Browser

Digestive System Diseases × Lymphoid × Clear all

Sleepiness, Arrhythmias, Cardiac, Cataract, Confusion, Coronary Artery Disease, Digestive System Diseases, Dizziness, Fatigue, Heart Failure, Hemorrhage, Hypersensitivity, Hypotension, Orthostatic, Hypothyroidism, Infections, Lymphoma, Peripheral Nervous System Diseases, Seizures, Thromboembolism, Tumor Lysis Syndrome, Neoplasms, Second Primary, Lung Diseases, Interstitial, Renal Insufficiency, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Teratogenesis

NCT04639115 2022-06-14

A Phase 1, Multicenter, Open-Label Study to Evaluate the Effect of Mild or Moderate Hepatic Impairment on the Multiple-Dose Pharmacokinetics of Ozanimod

Phase 1 Completed

26 enrolled

Lymphoid

Digestive System Diseases, Liver Diseases, Lymphoma, Follicular

NCT00210249 2022-02-04

PHRC2003

Completed

364 enrolled 4 charts

GenitourinaryGynecologicLymphoid

Urinary Bladder Diseases, Digestive System Diseases, Lung Diseases, Lymphoma, Neoplasms, Ovarian Diseases, Prostatic Diseases

Clinical Trials

Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)

A Phase 1, Multicenter, Open-Label Study to Evaluate the Effect of Mild or Moderate Hepatic Impairment on the Multiple-Dose Pharmacokinetics of Ozanimod

PHRC2003